INTRODUCING

VitriLife®

Groundbreaking stabilization & delivery enabling technology for your microbial and biological products

 

MISSION

We seek to become the leading global provider of biological stabilization and delivery solutions by offering our customers the most advanced formulation science and preservation technology available today for the protection of their biological materials from impacts to viability, stability, and functionality during long-term storage, transport, and distribution  

 

Our Markets

Biopharmaceuticals

The result is consistently delivering thermostable cold chain free formulations in the dry state at 37°C and higher with minimal to no activity losses over time.  

Microbiome Therapeutics 

The human body is home to trillions of microorganisms including bacteria, viruses, and fungi.  As we learn more about the potential microbiome modulating microbes have on human health, it is clear product companies need an effective alternative to lyophilization to produce thermally stable beneficial bacteria without losses in therapeutic value during manufacture and subsequent storage. 

UST has extensive expertise developing live ambient temperature stable formulations for the delivery of microbiome-based therapeutics in gut, skin, and vaginal applications.  

Agricultural Biologicals

Ensuring the efficacy, stability, and commercial viability of microbial products and their metabolites in real world conditions are among the biggest challenges in agriculture.  To reduce the environmental impact of farming while enhancing crop production, growers must see improvements in yield, longer shelf life, and compatibility with agrochemicals. 

Reach out to us to learn more about how UST's preservation and encapsulation technology can enhance the stability of your microbial products.

 

UST has a long track record of applying its stabilization and mucosal delivery enabling technologies to many of the world's most heat and freeze sensitive vaccines (e.g. polio, anthrax, rabies, influenza, others) and biologics (e.g. blood and blood components, stem cell derived products).  

 

ABOUT US

Universal Stabilization Technologies, Inc. ("UST") is a San Diego-based biopharmaceutical R&D company and provider of leading stabilization and delivery enabling technologies with higher yields and at higher storage temperatures than currently possible.  UST’s proprietary process allows the cost-effective stabilization and delivery of fragile biologicals from biomedical to agricultural applications during long-term storage, transport, and distribution.  UST also develops novel methods for mucosal and transdermal administration of labile biologicals.

© 2019 Universal Stabilization Technologies, Inc. All rights reserved.